Invasive Positive Pressure Ventilation for Chronic Respiratory Failure
In chronic respiratory failure, when the severity of hypoxemia and the underlying disease course indicate a need for invasive support, the selection and configuration of mechanical ventilation becomes the central clinical decision. The approach is guided by both disease context and ventilation strategy.
Treatment Approach
The structured protocol involves invasive positive pressure ventilation (IPPV). The ventilation strategy employed incorporates a lung-protective approach — the full regimen, clinical decision criteria, and parameter guidance are available in the complete protocol.
References
DOI: 10.1186/s40560-023-00658-3
In ARF, the choice between the use of nasal cannula, HFNC, NPPV, or invasive positive pressure ventilation (IPPV) is based on the presence of underlying disease and severity of hypoxemia.
Low tidal volume ventilation is weakly recommended for ARF in SSCG2021 and SRLF-GL2019, and strongly recommended for ARDS in JRS/JSICM/JSRCM-GL2021, SSCG2021, SRLF-GL2019 and FICM/ICS-GL2018.
View source ↗